Provided By PR Newswire
Last update: Oct 28, 2025
Dr. Love, a biopharmaceutical industry veteran, brings extensive executive leadership and board experience with proven success in creating shareholder value
Read more at prnewswire.com172.12
-4.41 (-2.5%)
Find more stocks in the Stock Screener


